Page 152 - 南京医科大学自然版

第46卷第10期
·1582 · 南 京 医 科 大 学 学 报 2026年10月

ies specific for Xenopus embryonic antigens［J］. PLoS cov，2024，10（1）：262
One，2014，9（10）：e107521 ［35］Guo Y L，Chen X Y，Hu J W，et al. The dual role of
［23］Denicola G M，Shackelford D B. Metabolic phenotypes， SLC7A11 in tumor drug resistance：mechanisms，chal⁃
dependencies，and adaptation in lung cancer［J］. Cold lenges，and therapeutic potential［J］. Am J Cancer Res，
Spring Harb Perspect Med，2021，11（11）：a037838 2025，15（10）：4516-4532
［24］Liu J，Zhang X B，Yang M J，et al. CircCOL1A1 promotes ［36］Ding Y G，Gao J，Chen J，et al. BUB1b impairs chemother⁃
proliferation，migration，and invasion of colorectal cancer apy sensitivity via resistance to ferroptosis in lung adeno⁃
（CRC）cells and glutamine metabolism through GLS1 up⁃ carcinoma［J］. Cell Death Dis，2024，15（7）：525
regulation by sponging miR ⁃ 214 ⁃ 3p［J］. J Cancer Res ［37］Long Y，Tao H P，Karachi A，et al. Dysregulation of gluta⁃
Clin Oncol，2024，150（4）：211 mate transport enhances Treg function that promotes
［25］Zhou S S，Wu H E，Chen Y，et al. Lifting the veil on VEGF blockade resistance in glioblastoma［J］. Cancer
tumor metabolism：a GDH1 ⁃ focused perspective［J］. Res，2020，80（3）：499-509
iScience，2025，28（6）：112551 ［38］Kim M J，Kim H S，Kang H W，et al. SLC38A5 modulates
［26］王道云，黄志诚，李博文，等. 代谢组学在肺癌研究中的 ferroptosis to overcome gemcitabine resistance in pancre⁃
应用及其研究进展［J］. 中国肺癌杂志，2025，28（7）： atic cancer［J］. Cells，2023，12（20）：2509
533-541 ［39］Ben⁃harari R R，Goodwin E，Casoy J. Adverse event pro⁃
Wang D Y，Huang Z C，Li B W，et al. Applications and ad⁃ file of pyrimethamine ⁃ based therapy in toxoplasmosis：a
vances of metabolomics in lung cancer research［J］. Chi⁃ systematic review［J］. Drugs R D，2017，17（4）：523-544
nese Journal of Lung Cancer，2025，28（7）：533-541 ［40］Anderson N M，Simon M C. The tumor microenviron⁃
［27］Jiang Z F，Wang M，Xu J L，et al. Hypoxia promotes mito⁃ ment［J］. Curr Biol，2020，30（16）：R921⁃R925
chondrial glutamine metabolism through HIF1α ⁃ GDH ［41］Hu X B，Ma Z F，Xu B B，et al. Glutamine metabolic mi⁃
pathway in human lung cancer cells［J］. Biochem Bio⁃ croenvironment drives M2 macrophage polarization to me⁃
phys Res Commun，2017，483（1）：32-38 diate trastuzumab resistance in HER2 ⁃ positive gastric
［28］Li Y J，Zhang C Y，Martincuks A，et al. STAT proteins in cancer［J］. Cancer Commun（Lond），2023，43（8）：909-
cancer：orchestration of metabolism［J］. Nat Rev Cancer， 937
2023，23（3）：115-134 ［42］Zhu Y H，Zhou Z W，Du X，et al. Cancer cell⁃derived argi⁃
［29］Lv H X，Han X，Yang Y S，et al. Glutamine：a new strate⁃ nine fuels polyamine biosynthesis in tumor ⁃ associated
gy for targeted metabolic therapy in the tumor microenvi⁃ macrophages to promote immune evasion［J］. Cancer
ronment［J］. Cell Death Discov，2025，11（1）：459 Cell，2025，43（6）：1045-1060
［30］Li X，Peng X Q，Li Y，et al. Glutamine addiction in tumor ［43］Feng B，Wu J Z，Shen B，et al. Cancer⁃associated fibro⁃
cell：oncogene regulation and clinical treatment［J］. Cell blasts and resistance to anticancer therapies：status，
Commun Signal，2024，22（1）：12 mechanisms，and countermeasures［J］. Cancer Cell Int，
［31］Sung Y，Yu Y C，Lee M，et al. Targeting cancer glutamine 2022，22（1）：166
dependency with a first⁃in⁃class inhibitor of the mitochon⁃ ［44］Li X，Zhu H M，Sun W X，et al. Role of glutamine and its
drial glutamine transporter SLC1A5_var［J］. Nat Com⁃ metabolite ammonia in crosstalk of cancer⁃associated fi⁃
mun，2025，16（1）：9690 broblasts and cancer cells［J］. Cancer Cell Int，2021，21
［32］Thongpon P，Intuyod K，Chomwong S，et al. Curcumin syn⁃ （1）：479
ergistically enhances the efficacy of gemcitabine against ［45］Masuda H. Cancer⁃associated fibroblasts in cancer drug
gemcitabine⁃resistant cholangiocarcinoma via the target⁃ resistance and cancer progression：a review［J］. Cell
ing LAT2/glutamine pathway［J］. Sci Rep，2024，14（1）： Death Discov，2025，11：341
16059 ［46］Muir A，Danai L V，Gui D Y，et al. Environmental cystine
［33］Feng M Y，Xiong G B，Cao Z，et al. LAT2 regulates gluta⁃ drives glutamine anaplerosis and sensitizes cancer cells
mine ⁃ dependent mTOR activation to promote glycolysis to glutaminase inhibition［J］. Elife，2017，6：e27713
and chemoresistance in pancreatic cancer［J］. J Exp Clin ［47］Chen R，Lai L A，Sullivan Y，et al. Disrupting glutamine
Cancer Res，2018，37（1）：274 metabolic pathways to sensitize gemcitabine⁃resistant pan⁃
［34］Liu X X，Huang Z H，Chen Q Z，et al. Hypoxia⁃induced creatic cancer［J］. Sci Rep，2017，7（1）：7950
epigenetic regulation of miR⁃485⁃3p promotes stemness ［48］Wong C C，Xu J Y，Bian X Q，et al. In colorectal cancer
and chemoresistance in pancreatic ductal adenocarcino⁃ cells with mutant KRAS，SLC25A22⁃mediated glutaminol⁃
ma via SLC7A11⁃mediated ferroptosis［J］. Cell Death Dis⁃ ysis reduces DNA demethylation to increase WNT signal⁃